Arnold S. Bayer

40.4k total citations · 5 hit papers
372 papers, 27.7k citations indexed

About

Arnold S. Bayer is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Arnold S. Bayer has authored 372 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 272 papers in Infectious Diseases, 183 papers in Epidemiology and 124 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Arnold S. Bayer's work include Antimicrobial Resistance in Staphylococcus (247 papers), Infective Endocarditis Diagnosis and Management (162 papers) and Streptococcal Infections and Treatments (120 papers). Arnold S. Bayer is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (247 papers), Infective Endocarditis Diagnosis and Management (162 papers) and Streptococcal Infections and Treatments (120 papers). Arnold S. Bayer collaborates with scholars based in United States, Germany and Spain. Arnold S. Bayer's co-authors include Michael R. Yeaman, Michael J. Rybak, Henry F. Chambers, Ambrose L. Cheung, Yan Q. Xiong, Barbara E. Murray, Vance G. Fowler, Adolf W. Karchmer, Nagendra N. Mishra and Lucien B. Guze and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Arnold S. Bayer

366 papers receiving 26.5k citations

Hit Papers

Clinical Practice Guidelines by the Infectious Diseases S... 2005 2026 2012 2019 2011 2015 2005 2011 2005 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
    2011 3.1k citations Arnold S. Bayer, Henry F. Chambers et al. Clinical Infectious Diseases profile →
  2. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
    2015 1.9k citations Arnold S. Bayer, Vance G. Fowler et al. profile →
  3. Infective Endocarditis
    2005 1.2k citations Arnold S. Bayer, Vance G. Fowler et al. profile →
  4. Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
    2011 1.2k citations Arnold S. Bayer, Henry F. Chambers et al. Clinical Infectious Diseases profile →
  5. Necrotizing Fasciitis Caused by Community-Associated Methicillin-ResistantStaphylococcus aureusin Los Angeles
    2005 760 citations Arnold S. Bayer, Brad Spellberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnold S. Bayer United States 82 16.3k 10.6k 7.5k 7.1k 5.9k 372 27.7k
Barbara E. Murray United States 79 19.6k 1.2× 7.6k 0.7× 9.5k 1.3× 5.8k 0.8× 9.8k 1.7× 334 35.4k
Vance G. Fowler United States 82 16.2k 1.0× 14.9k 1.4× 5.6k 0.7× 7.6k 1.1× 7.0k 1.2× 400 31.3k
Henry F. Chambers United States 74 19.0k 1.2× 6.6k 0.6× 7.3k 1.0× 6.9k 1.0× 9.2k 1.6× 257 27.6k
Michael J. Rybak United States 76 17.4k 1.1× 8.3k 0.8× 3.9k 0.5× 4.2k 0.6× 9.8k 1.7× 426 27.2k
Sheldon L. Kaplan United States 69 11.3k 0.7× 11.1k 1.1× 2.3k 0.3× 7.5k 1.1× 5.1k 0.9× 361 26.0k
Emilio Bouza Spain 77 15.8k 1.0× 15.9k 1.5× 2.5k 0.3× 3.5k 0.5× 3.6k 0.6× 862 29.3k
Henri A. Verbrugh Netherlands 72 11.8k 0.7× 5.9k 0.6× 6.1k 0.8× 2.7k 0.4× 4.5k 0.8× 387 22.8k
Alex van Belkum Netherlands 81 15.0k 0.9× 5.8k 0.6× 9.9k 1.3× 3.0k 0.4× 6.6k 1.1× 528 28.6k
Richard P. Wenzel United States 72 10.9k 0.7× 8.2k 0.8× 2.7k 0.4× 2.5k 0.4× 4.4k 0.7× 241 21.3k
David H. Persing United States 76 13.2k 0.8× 8.1k 0.8× 4.7k 0.6× 3.3k 0.5× 2.9k 0.5× 259 26.6k

Countries citing papers authored by Arnold S. Bayer

Since Specialization
Citations

This map shows the geographic impact of Arnold S. Bayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold S. Bayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold S. Bayer more than expected).

Fields of papers citing papers by Arnold S. Bayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnold S. Bayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold S. Bayer. The network helps show where Arnold S. Bayer may publish in the future.

Co-authorship network of co-authors of Arnold S. Bayer

This figure shows the co-authorship network connecting the top 25 collaborators of Arnold S. Bayer. A scholar is included among the top collaborators of Arnold S. Bayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnold S. Bayer. Arnold S. Bayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swift, Steven M., Xavier Vila‐Farrés, Wessam Abdelhady, et al.. (2024). The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia. The Journal of Infectious Diseases. 230(2). 309–318. 3 indexed citations
2.
Bayer, Arnold S., Christian Beck, Jacob Biboy, et al.. (2024). Staphylococcus aureus Stress Response to Bicarbonate Depletion. International Journal of Molecular Sciences. 25(17). 9251–9251. 1 indexed citations
3.
Proctor, Richard A., Selvi C. Ersoy, Adhar C. Manna, et al.. (2023). Role of the NaHCO 3 Transporter MpsABC in the NaHCO 3 –β-Lactam-Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus. Microbiology Spectrum. 11(3). e0014123–e0014123. 2 indexed citations
4.
Ersoy, Selvi C., Adhar C. Manna, Rita G. Sobral, et al.. (2022). Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCO 3 -Responsive and Nonresponsive Methicillin-Resistant Staphylococcus aureus. Microbiology Spectrum. 10(6). e0342222–e0342222. 6 indexed citations
5.
Ersoy, Selvi C., Liana C. Chan, Michael R. Yeaman, et al.. (2022). Impacts of NaHCO3 on β-Lactam Binding to PBP2a Protein Variants Associated with the NaHCO3-Responsive versus NaHCO3-Non-Responsive Phenotypes. Antibiotics. 11(4). 462–462. 7 indexed citations
6.
Huang, David B., et al.. (2021). Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 65(8). e0050821–e0050821. 5 indexed citations
7.
Xiong, Yan Q., Wessam Abdelhady, Youngju Pak, et al.. (2020). Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography. Antimicrobial Agents and Chemotherapy. 64(7). 14 indexed citations
8.
Ersoy, Selvi C., Wessam Abdelhady, Liang Li, et al.. (2019). Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to β-Lactam Antibiotics. Antimicrobial Agents and Chemotherapy. 63(7). 28 indexed citations
9.
10.
Indiani, Chiara, Assaf Raz, Wessam Abdelhady, et al.. (2019). The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-ResistantStaphylococcus aureusBacteriolysis. Antimicrobial Agents and Chemotherapy. 63(4). 56 indexed citations
11.
Lauridsen, Trine K., Lawrence Park, Steven Y. C. Tong, et al.. (2015). Echocardiographic Findings Predict In-Hospital and 1-Year Mortality in Left-Sided Native Valve Staphylococcus aureus Endocarditis. Circulation Cardiovascular Imaging. 8(7). e003397–e003397. 42 indexed citations
12.
Yang, Soo‐Jin, Yan Q. Xiong, Michael R. Yeaman, et al.. (2013). Role of the LytSR Two-Component Regulatory System in Adaptation to Cationic Antimicrobial Peptides in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 57(8). 3875–3882. 33 indexed citations
13.
Dhand, Abhay, Arnold S. Bayer, Joe Pogliano, et al.. (2011). Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding. Clinical Infectious Diseases. 53(2). 158–163. 201 indexed citations
14.
Spellberg, Brad, Ashraf S. Ibrahim, Michael R. Yeaman, et al.. (2008). The Antifungal Vaccine Derived from the Recombinant N Terminus of Als3p Protects Mice against the Bacterium Staphylococcus aureus. Infection and Immunity. 76(10). 4574–4580. 123 indexed citations
15.
Spellberg, Brad, et al.. (2004). Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6. Journal of Antimicrobial Chemotherapy. 54(4). 832–835. 69 indexed citations
16.
Kupferwasser, Leon Iri, Michael R. Yeaman, Cynthia C. Nast, et al.. (2003). Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. Journal of Clinical Investigation. 112(2). 222–233. 120 indexed citations
17.
Cheung, Ambrose L., Arnold S. Bayer, Gongyi Zhang, Hattie D. Gresham, & Yan-Qiong Xiong. (2003). Regulation of virulence determinants in vitro and in vivo inStaphylococcus aureus. FEMS Immunology & Medical Microbiology. 40(1). 1–9. 362 indexed citations
18.
Fowler, Vance G., Lauren M. McIntyre, Michael R. Yeaman, et al.. (2000). In Vitro Resistance to Thrombin‐Induced Platelet Microbicidal Protein in Isolates ofStaphylococcus aureusfrom Endocarditis Patients Correlates with an Intravascular Device Source. The Journal of Infectious Diseases. 182(4). 1251–1254. 47 indexed citations
19.
Cheung, A L, et al.. (1994). Diminished Virulence Of A Sar-lagr- Mutant Of Staphylococcus Aureus In The Rabbit Model Of Endocarditis. Scopus. 3 indexed citations
20.
Nelson, Ronald J., Daniel P. Harley, William J. French, & Arnold S. Bayer. (1984). Favorable ten-year experience with valve procedures for active infective endocarditis. Journal of Thoracic and Cardiovascular Surgery. 87(4). 493–502. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara E. Murray Breakdown of academic impact, for papers by Vance G. Fowler Breakdown of academic impact, for papers by Henry F. Chambers Breakdown of academic impact, for papers by Michael J. Rybak Breakdown of academic impact, for papers by Sheldon L. Kaplan Breakdown of academic impact, for papers by Emilio Bouza Breakdown of academic impact, for papers by Henri A. Verbrugh Breakdown of academic impact, for papers by Alex van Belkum Breakdown of academic impact, for papers by Richard P. Wenzel Breakdown of academic impact, for papers by David H. Persing
Rankless by CCL
2026